跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Authorized
STANDARD
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
TERUMO BCT, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0a424aa0362d9225
Company
TERUMO BCT, INC.
Type
Standard
Approval Details
Approval Id
0a424aa0362d9225
Drug Approval Canada Name
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Product Name
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Status
Marketed
Status Date
2018-06-20
Original Market Date
2018-06-20
Din
02469731
Drug Class
Human
Dosage Form
Solution
Route Of Administration
0-Unassigned
Schedule
Ethical
Ahfs
20:12.04.92
Atc Original
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Atc Name
v 07 ac
Aig Number
0359691001
Company Name
TERUMO BCT, INC.
Company Address
10811 W Collins Ave, Lakewood, Colorado, United States, 80215
Company Detail Path
/organization/terumo-bct-inc
Company Information
Pharmaceutical Company Name
TERUMO BCT, INC.
Country Name
United States
Province Name
Colorado
City Name
lakewood,colorado,country_us
Address
1158 West Collins Ave
Active Ingredients
CITRIC ACID MONOHYDRATE
0.8 G / 100 ML
DEXTROSE
2.45 G / 100 ML
SODIUM CITRATE DIHYDRATE
2.2 G / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0a424aa0362d9225
Type
Standard
Back to Health Canada Approvals